About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
E
Building on Experience: Optimizing Treatment of Lower Risk MDS
By
Esther Natalie Oliva
2 Videos
162 views
August 8, 2018
0 Comments
Login to view comments.
Click here to Login
Featured Video
24:55
Treatment Considerations in CLL: Challenging Patient Cases
Treatment Considerations in Front-line CLL
Feat.
A. Zelenetz
Featured Video
15:18
Treatment Considerations in CLL: Challenging Patient Cases
Treatment Considerations for Ibrutinib-Intolerant Patients - A Patie…
Feat.
M. Shadman
Related Content
AUTOPLAY
ON
22:37
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of Acute Leukemia and MDS - Highlig…
Feat.
T. Badar
21:05
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
Feat.
R. Gale
12:36
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Myeloid for Measure - New Therapeutics in…
Feat.
A. Patel
44:26
University of Colorado Division of Hematology
Novel Therapies in AML and MDS
Feat.
D. Pollyea
13:07
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Venetoclax With Azacitidine for Pts With Tr…
Feat.
J. Garcia
16:55
Moffitt Cancer Center
Making Sense of the New Classification Systems for MDS in 2024
Feat.
R. Komrokji
09:27
ASH 2022 Conference Coverage
MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…
Feat.
M. McMullin
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Overview of Hematopoietic Cell Transplantation
Feat.
R. Salit
16:25
Northwestern Medicine Oncology and Hematology
Diagnosis and Goals of Therapy in PV
Feat.
B. Stein
29:20
MyCancerHaven
Experts Discuss Recent Advances in MDS
Feat.
R. Vij,
M. Sekeres
14:34
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "IMerge - Results From a Ph3 Study of Imet…
Feat.
A. Zeidan
30:34
UChicago Medicine
2023 Updates in AML and MDS
Feat.
O. Odenike
16:50
MDS Foundation
Pre-MDS States: How to Manage CHIP, CCUS and ICUS in the Clinic
Feat.
M. Savona
14:53
Talha Badar
DDX41 Mutated Germline Predisposition Syndrome-Associated Myeloid Ne…
16:27
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Update on CHIP and CCUS
Feat.
L. Weeks
04:11
Total Health
ASCO 2022 Updates in Leukemia and MDS
Feat.
D. Sallman
11:41
Penn Medicine Abramson Cancer Center
Penn Medicine Updates From Recent Meetings in Hematologic Malignanci…
Feat.
C. Lai
07:56
MDS Foundation
Debates in HR-MDS: Cytoreduction Should Precede Allo-HCT
Feat.
U. Platzbecker
33:44
PleXus Communications
Low-Risk MDS in Community Practice: How Recent Advances Will Benefit…
Feat.
G. Garcia-Manero
51:20
Jerry Spivak
Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…